1. Impact of Therapeutic Drug level monitoring on outcomes of patients with Crohn’s Disease treated with Infliximab: real world data from a retrospective single centre cohort study.
N Kamperidis, P Middleton, T Tyrrell, I Stasinos, N Arebi
Frontline Gastroetnerology, 2019
2. Monitoring of biologics in Inflammatory Bowel Disease (IBD) patients using the Patients Know Best electronic portal: Pilot study of update, acceptability and outcomes.
N Kamperidis, M O’Connor, N Arebi
Gastrointestinal Nursing, 2018
3. Effectiveness and safety of Vedolizumab in anti-TNF naïve patients with Iinflammatory Bowel Disease – A multicentre retrospective European study.
Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M
Inflammatory Bowel Disease, 2018
4. The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery.
Kamperidis N, Faiz O, Arebi N.
Annals of Surgery, 2017
5. Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.
Goodhand JR, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury FA, Croft NM, Direkze N, Langmead L, Irving PM, Rampton DS, Lindsay JO.
Alimentary Pharmacology Therapeutics, 2013
6. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent.
Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL,Lindsay JO, Rampton DS.
Alimentary Pharmacology Therapeutics, 2012
7. Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory Bowel disease.
Kamperidis N, Goodhand JR, Chowdhury FA, Koodun Y, Direzke NC, Naik S, Sanderson IR, Croft NM, Langmead FL, Irving PM, Rampton DS, Lindsay JO.
Journal of Pediatric Gastroenterology and Nutrition, 2012
8. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease.
Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM, Lindsay JO, Sanderson IR, Rampton DS.
Inflamm Bowel Dis. 2012
9. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.
Goodhand JR, Kamperidis N, Nguyen
